<SEC-DOCUMENT>9999999997-16-027998-index.html : 20161222
<SEC-HEADER>9999999997-16-027998.hdr.sgml : 20161222
<ACCEPTANCE-DATETIME>20161222153859
ACCESSION NUMBER:		9999999997-16-027998
CONFORMED SUBMISSION TYPE:	CT ORDER
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20161222
DATE AS OF CHANGE:		20161222
<ACTION-DATE>20161222
<RECEIVED-DATE>20161222

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Intellia Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001652130
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				364785571
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CT ORDER
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-37766
		FILM NUMBER:		162066504

	BUSINESS ADDRESS:	
		STREET 1:		130 BROOKLINE STREET
		STREET 2:		SUITE 201
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		857-285-6200

	MAIL ADDRESS:	
		STREET 1:		130 BROOKLINE STREET
		STREET 2:		SUITE 201
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
</SEC-HEADER>
<DOCUMENT>
<TYPE>CT ORDER
<SEQUENCE>1
<FILENAME>filename1.pdf
<TEXT>
Document 1 - file: filename1.pdf

</DOCUMENT>
</SEC-DOCUMENT>